Company: TOMZ
Filing Date: 2025-09-30
Form Type: ARS
Source: 0001654954-25-011264
Chunk: 53

Company: TOMI Environmental Solutions, Inc.
Filing Date: 2025-09-30
Form: ARS
Chunk 53
---
 the unit has eight (8) outputs where four (4) are dedicated to our regular process of Constant or Pulse Injection, Dwell, and Aeration along with a light beacon status bar and four (4) are programmable to meet the customer needs for any external equipment they may desire to work with the system. This system is currently on the market and remains to be one of our most popular quoted product lines, has been implemented by customers, and is receiving praise for its further developments.

Our SteraMist® BIT™ solution product line is currently made up of a 32-ounce bottle for the SteraPak, a ten (10) liter, five (5) gallon, 55-gallon drum for our custom built-ins and our traditional one (1) gallon bottle. This brings the BIT Solution product line to a total of five (5) options provided to our customers, which will benefit our razor/razor-blade business model, where our SteraMist delivery systems represent the razor, and our proprietary BIT Solution represents the razor blade.

We expect these new products and service introductions will positively impact our net sales, cost of sales and operating expenses during this fiscal year.

Supply Chain:

We have orders for supplies and materials that are required in our equipment and are prepared to continue the manufacturing of all our products. Further, TOMI has multiple suppliers, outsourced engineers, and software programmers to turn to for the manufacturing and installation of its SteraMist products to reduce the risks associated with the current supply chain environment.

| 33 |

Financial Operations Overview

Our financial position as of December 31, 2024 and 2023, respectively, was as follows:

|                                                  |     |   | December 31,  2024 |     |   | December 31,  2023 |
|:-------------------------------------------------|:----|:--|-------------------:|:----|:--|-------------------:|
| Total shareholders’ equity                       |     | $ |          4,099,000 |     | $ |          8,359,000 |
| Cash and cash equivalents                        |     | $ |            665,000 |     | $ |          2,339,000 |
| Deferred Revenue                                 |     | $ |            212,000 |     | $ |                  - |
| Accounts receivable – Current, net               |     | $ |          1,881,000 |     | $ |          2,430